{"id":63,"date":"2010-11-20T20:27:01","date_gmt":"2010-11-20T20:27:01","guid":{"rendered":"https:\/\/blogs.bmj.com\/jmg\/?p=63"},"modified":"2026-02-22T00:29:23","modified_gmt":"2026-02-22T00:29:23","slug":"colorectal-cancer-susceptibility-loci-on-chromosome-8q23-3-and-11q23-1-as-modifiers-for-disease-expression-in-lynch-syndrome","status":"publish","type":"post","link":"https:\/\/blogs.bmj.com\/jmg\/2010\/11\/20\/colorectal-cancer-susceptibility-loci-on-chromosome-8q23-3-and-11q23-1-as-modifiers-for-disease-expression-in-lynch-syndrome\/","title":{"rendered":"Colorectal cancer susceptibility loci on chromosome 8q23.3 and 11q23.1 as modifiers for disease expression in lynch syndrome (Contributed by Dr. Bente Talseth-Palmer)"},"content":{"rendered":"

Lynch syndrome confers a high lifetime risk of developing cancer, especially colorectal and endometrial cancer. Recently, six genomic regions have been identified that increase colorectal cancer (CRC) risk in the general population and two of these regions are associated with an increased risk of developing CRC in Lynch syndrome patients. The results of this study further confirmed that these two chromosomal regions (8q23.3 and 11q23) influenced the risk of developing CRC as well as the age of diagnosis of CRC in Lynch syndrome patients that have MLH1 mutations. (http:\/\/jmg.bmj.com\/content\/early\/2010\/11\/19\/jmg.2010.079962.abstract?papetoc<\/a> )<\/p>\n","protected":false},"excerpt":{"rendered":"

Lynch syndrome confers a high lifetime risk of developing cancer, especially colorectal and endometrial cancer. Recently, six genomic regions have been identified that increase colorectal cancer (CRC) risk in the general population and two of these regions are associated with an increased risk of developing CRC in Lynch syndrome patients. The results of this study […]<\/p>\n

Read More…<\/a><\/p>\n","protected":false},"author":123,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-63","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"yoast_head":"\nColorectal cancer susceptibility loci on chromosome 8q23.3 and 11q23.1 as modifiers for disease expression in lynch syndrome (Contributed by Dr. Bente Talseth-Palmer) - JMG Contact blog<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/blogs.bmj.com\/jmg\/2010\/11\/20\/colorectal-cancer-susceptibility-loci-on-chromosome-8q23-3-and-11q23-1-as-modifiers-for-disease-expression-in-lynch-syndrome\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Colorectal cancer susceptibility loci on chromosome 8q23.3 and 11q23.1 as modifiers for disease expression in lynch syndrome (Contributed by Dr. Bente Talseth-Palmer) - JMG Contact blog\" \/>\n<meta property=\"og:description\" content=\"Lynch syndrome confers a high lifetime risk of developing cancer, especially colorectal and endometrial cancer. Recently, six genomic regions have been identified that increase colorectal cancer (CRC) risk in the general population and two of these regions are associated with an increased risk of developing CRC in Lynch syndrome patients. The results of this study [...]Read More...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/blogs.bmj.com\/jmg\/2010\/11\/20\/colorectal-cancer-susceptibility-loci-on-chromosome-8q23-3-and-11q23-1-as-modifiers-for-disease-expression-in-lynch-syndrome\/\" \/>\n<meta property=\"og:site_name\" content=\"JMG Contact blog\" \/>\n<meta property=\"article:published_time\" content=\"2010-11-20T20:27:01+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-22T00:29:23+00:00\" \/>\n<meta name=\"author\" content=\"hqqu\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@HuiQiQu\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"hqqu\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2010\\\/11\\\/20\\\/colorectal-cancer-susceptibility-loci-on-chromosome-8q23-3-and-11q23-1-as-modifiers-for-disease-expression-in-lynch-syndrome\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2010\\\/11\\\/20\\\/colorectal-cancer-susceptibility-loci-on-chromosome-8q23-3-and-11q23-1-as-modifiers-for-disease-expression-in-lynch-syndrome\\\/\"},\"author\":{\"name\":\"hqqu\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/person\\\/be0250f8d5b52412c3e7c222dabd591b\"},\"headline\":\"Colorectal cancer susceptibility loci on chromosome 8q23.3 and 11q23.1 as modifiers for disease expression in lynch syndrome (Contributed by Dr. Bente Talseth-Palmer)\",\"datePublished\":\"2010-11-20T20:27:01+00:00\",\"dateModified\":\"2026-02-22T00:29:23+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2010\\\/11\\\/20\\\/colorectal-cancer-susceptibility-loci-on-chromosome-8q23-3-and-11q23-1-as-modifiers-for-disease-expression-in-lynch-syndrome\\\/\"},\"wordCount\":119,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#organization\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2010\\\/11\\\/20\\\/colorectal-cancer-susceptibility-loci-on-chromosome-8q23-3-and-11q23-1-as-modifiers-for-disease-expression-in-lynch-syndrome\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2010\\\/11\\\/20\\\/colorectal-cancer-susceptibility-loci-on-chromosome-8q23-3-and-11q23-1-as-modifiers-for-disease-expression-in-lynch-syndrome\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2010\\\/11\\\/20\\\/colorectal-cancer-susceptibility-loci-on-chromosome-8q23-3-and-11q23-1-as-modifiers-for-disease-expression-in-lynch-syndrome\\\/\",\"name\":\"Colorectal cancer susceptibility loci on chromosome 8q23.3 and 11q23.1 as modifiers for disease expression in lynch syndrome (Contributed by Dr. Bente Talseth-Palmer) - JMG Contact blog\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#website\"},\"datePublished\":\"2010-11-20T20:27:01+00:00\",\"dateModified\":\"2026-02-22T00:29:23+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2010\\\/11\\\/20\\\/colorectal-cancer-susceptibility-loci-on-chromosome-8q23-3-and-11q23-1-as-modifiers-for-disease-expression-in-lynch-syndrome\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2010\\\/11\\\/20\\\/colorectal-cancer-susceptibility-loci-on-chromosome-8q23-3-and-11q23-1-as-modifiers-for-disease-expression-in-lynch-syndrome\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2010\\\/11\\\/20\\\/colorectal-cancer-susceptibility-loci-on-chromosome-8q23-3-and-11q23-1-as-modifiers-for-disease-expression-in-lynch-syndrome\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Colorectal cancer susceptibility loci on chromosome 8q23.3 and 11q23.1 as modifiers for disease expression in lynch syndrome (Contributed by Dr. Bente Talseth-Palmer)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#website\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/\",\"name\":\"JMG Contact blog\",\"description\":\"JMG Contact blog\",\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#organization\",\"name\":\"JMG Contact blog\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/files\\\/2017\\\/10\\\/blog-logo-jmg.png\",\"contentUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/files\\\/2017\\\/10\\\/blog-logo-jmg.png\",\"width\":300,\"height\":34,\"caption\":\"JMG Contact blog\"},\"image\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/person\\\/be0250f8d5b52412c3e7c222dabd591b\",\"name\":\"hqqu\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g\",\"caption\":\"hqqu\"},\"description\":\"Huiqi Qu has a background as a physician trained in internal medicine and a PhD in Experimental Medicine (Endocrinology). His research applies human genetics and multi-omics to complex and pediatric diseases, including GWAS, polygenic risk scores (PRS), single-cell transcriptomics, and integrative genomics to support precision medicine and clinical translation.\",\"sameAs\":[\"https:\\\/\\\/x.com\\\/HuiQiQu\"],\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/author\\\/hqiqu\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Colorectal cancer susceptibility loci on chromosome 8q23.3 and 11q23.1 as modifiers for disease expression in lynch syndrome (Contributed by Dr. Bente Talseth-Palmer) - JMG Contact blog","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/blogs.bmj.com\/jmg\/2010\/11\/20\/colorectal-cancer-susceptibility-loci-on-chromosome-8q23-3-and-11q23-1-as-modifiers-for-disease-expression-in-lynch-syndrome\/","og_locale":"en_US","og_type":"article","og_title":"Colorectal cancer susceptibility loci on chromosome 8q23.3 and 11q23.1 as modifiers for disease expression in lynch syndrome (Contributed by Dr. Bente Talseth-Palmer) - JMG Contact blog","og_description":"Lynch syndrome confers a high lifetime risk of developing cancer, especially colorectal and endometrial cancer. Recently, six genomic regions have been identified that increase colorectal cancer (CRC) risk in the general population and two of these regions are associated with an increased risk of developing CRC in Lynch syndrome patients. The results of this study [...]Read More...","og_url":"https:\/\/blogs.bmj.com\/jmg\/2010\/11\/20\/colorectal-cancer-susceptibility-loci-on-chromosome-8q23-3-and-11q23-1-as-modifiers-for-disease-expression-in-lynch-syndrome\/","og_site_name":"JMG Contact blog","article_published_time":"2010-11-20T20:27:01+00:00","article_modified_time":"2026-02-22T00:29:23+00:00","author":"hqqu","twitter_card":"summary_large_image","twitter_creator":"@HuiQiQu","twitter_misc":{"Written by":"hqqu","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/blogs.bmj.com\/jmg\/2010\/11\/20\/colorectal-cancer-susceptibility-loci-on-chromosome-8q23-3-and-11q23-1-as-modifiers-for-disease-expression-in-lynch-syndrome\/#article","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/jmg\/2010\/11\/20\/colorectal-cancer-susceptibility-loci-on-chromosome-8q23-3-and-11q23-1-as-modifiers-for-disease-expression-in-lynch-syndrome\/"},"author":{"name":"hqqu","@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/person\/be0250f8d5b52412c3e7c222dabd591b"},"headline":"Colorectal cancer susceptibility loci on chromosome 8q23.3 and 11q23.1 as modifiers for disease expression in lynch syndrome (Contributed by Dr. Bente Talseth-Palmer)","datePublished":"2010-11-20T20:27:01+00:00","dateModified":"2026-02-22T00:29:23+00:00","mainEntityOfPage":{"@id":"https:\/\/blogs.bmj.com\/jmg\/2010\/11\/20\/colorectal-cancer-susceptibility-loci-on-chromosome-8q23-3-and-11q23-1-as-modifiers-for-disease-expression-in-lynch-syndrome\/"},"wordCount":119,"commentCount":0,"publisher":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#organization"},"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/blogs.bmj.com\/jmg\/2010\/11\/20\/colorectal-cancer-susceptibility-loci-on-chromosome-8q23-3-and-11q23-1-as-modifiers-for-disease-expression-in-lynch-syndrome\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/blogs.bmj.com\/jmg\/2010\/11\/20\/colorectal-cancer-susceptibility-loci-on-chromosome-8q23-3-and-11q23-1-as-modifiers-for-disease-expression-in-lynch-syndrome\/","url":"https:\/\/blogs.bmj.com\/jmg\/2010\/11\/20\/colorectal-cancer-susceptibility-loci-on-chromosome-8q23-3-and-11q23-1-as-modifiers-for-disease-expression-in-lynch-syndrome\/","name":"Colorectal cancer susceptibility loci on chromosome 8q23.3 and 11q23.1 as modifiers for disease expression in lynch syndrome (Contributed by Dr. Bente Talseth-Palmer) - JMG Contact blog","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#website"},"datePublished":"2010-11-20T20:27:01+00:00","dateModified":"2026-02-22T00:29:23+00:00","breadcrumb":{"@id":"https:\/\/blogs.bmj.com\/jmg\/2010\/11\/20\/colorectal-cancer-susceptibility-loci-on-chromosome-8q23-3-and-11q23-1-as-modifiers-for-disease-expression-in-lynch-syndrome\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/blogs.bmj.com\/jmg\/2010\/11\/20\/colorectal-cancer-susceptibility-loci-on-chromosome-8q23-3-and-11q23-1-as-modifiers-for-disease-expression-in-lynch-syndrome\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/blogs.bmj.com\/jmg\/2010\/11\/20\/colorectal-cancer-susceptibility-loci-on-chromosome-8q23-3-and-11q23-1-as-modifiers-for-disease-expression-in-lynch-syndrome\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/blogs.bmj.com\/jmg\/"},{"@type":"ListItem","position":2,"name":"Colorectal cancer susceptibility loci on chromosome 8q23.3 and 11q23.1 as modifiers for disease expression in lynch syndrome (Contributed by Dr. Bente Talseth-Palmer)"}]},{"@type":"WebSite","@id":"https:\/\/blogs.bmj.com\/jmg\/#website","url":"https:\/\/blogs.bmj.com\/jmg\/","name":"JMG Contact blog","description":"JMG Contact blog","publisher":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/blogs.bmj.com\/jmg\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/blogs.bmj.com\/jmg\/#organization","name":"JMG Contact blog","url":"https:\/\/blogs.bmj.com\/jmg\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/logo\/image\/","url":"https:\/\/blogs.bmj.com\/jmg\/files\/2017\/10\/blog-logo-jmg.png","contentUrl":"https:\/\/blogs.bmj.com\/jmg\/files\/2017\/10\/blog-logo-jmg.png","width":300,"height":34,"caption":"JMG Contact blog"},"image":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/person\/be0250f8d5b52412c3e7c222dabd591b","name":"hqqu","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g","caption":"hqqu"},"description":"Huiqi Qu has a background as a physician trained in internal medicine and a PhD in Experimental Medicine (Endocrinology). His research applies human genetics and multi-omics to complex and pediatric diseases, including GWAS, polygenic risk scores (PRS), single-cell transcriptomics, and integrative genomics to support precision medicine and clinical translation.","sameAs":["https:\/\/x.com\/HuiQiQu"],"url":"https:\/\/blogs.bmj.com\/jmg\/author\/hqiqu\/"}]}},"_links":{"self":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/posts\/63","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/users\/123"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/comments?post=63"}],"version-history":[{"count":0,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/posts\/63\/revisions"}],"wp:attachment":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/media?parent=63"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/categories?post=63"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/tags?post=63"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}